Click a link below to view the mailing archive as if it had been sent to you.
| 2015-10-31 12:15 | | New Diabetes Study Shows How Big Data Might Drive Precision Medicine and more... |
| 2015-10-31 00:15 | | Pfizer, Allergan Said to Aim to Agree on Deal by Thanksgiving and more... |
| 2015-10-30 12:15 | | AstraZeneca's olaparib looks promising for a targeted set of prostate cancer patients and more... |
| 2015-10-30 00:15 | | Pfizer-Allergan Deal Review Would Hinge on Individual Drugs and more... |
| 2015-10-29 12:15 | | Here Is Why Pfizer Inc Should Acquire Allergan PLC and more... |
| 2015-10-29 00:15 | | Pfizer Approached Allergan About Merger: WSJ and more... |
| 2015-10-28 12:15 | | Merck says it won't need AbbVie-sized discounts to win in hep C and more... |
| 2015-10-28 00:15 | | FDA Releases Theranos Inspection Reports and more... |
| 2015-10-27 12:15 | | Amgen, Cytokinetics heart failure drug succeeds in mid-stage study and more... |
| 2015-10-27 00:15 | | Here's how Raleigh's BioDelivery plans to spend $50 million and more... |
| 2015-10-26 12:15 | | Sales reps need to bone up on tech skills as drug launches move digital and more... |
| 2015-10-26 00:15 | | Battle Royale: Merck & Co. vs. Pfizer and more... |
| 2015-10-25 00:15 | | Turing CEO Martin Shkreli Unapologetic for 5,000% Drug Price Hike and more... |
| 2015-10-24 00:15 | | Drugmakers Are Distancing Themselves From Valeant and more... |
| 2015-10-23 12:15 | | FDA approves J&J's chemotherapy Yondelis and more... |
| 2015-10-23 00:15 | | FDA issues warning on AbbVie hep C drugs and drugmaker's shares fall 10% and more... |
| 2015-10-22 12:15 | | Zafgen says FDA will still review data from trial despite patient death and more... |
| 2015-10-22 00:15 | | New Patent Rules Pit Wall Street Against Big Pharma and more... |
| 2015-10-21 12:15 | | Will Pfizer's Bedside Manner Seduce Allergan? and more... |
| 2015-10-21 00:15 | | Glaxo, Pfizer, U.K. Form $100 Million Alzheimer's Research Fund and more... |
| 2015-10-20 12:15 | | Johnson & Johnson Tells Gilead Sciences "Game On" and more... |
| 2015-10-20 00:15 | | Lexington biotech gets two new cancer drugs, plans clinical trials next year and more... |
| 2015-10-19 12:15 | | One year after FDA nod, Eli Lilly's Trulicity launches first consumer campaign and more... |
| 2015-10-18 00:15 | | Boehringer wins FDA approval for its Pradaxa antidote with eyes on a bigger market share and more... |
| 2015-10-17 00:15 | | The FDA Turns Pfizer Away, but Few Are Surprised and more... |
| 2015-10-16 12:15 | | Gamida Cell pockets $5M from Novartis ahead of mooted financing round and more... |
| 2015-10-16 00:15 | | FDA ‘Weirdness?’ Separate meetings for BioMarin and Sarepta DMD drugs and more... |
| 2015-10-15 12:15 | | Merck’s CETP inhibitor seems to have very low chances of success after Eli Lilly’s similar drug failed in its late stages and more... |
| 2015-10-15 00:15 | | Allergan plots 117 job cuts in the wake of Kythera buyout and more... |
| 2015-10-14 12:15 | | AbbVie's Humira, J&J's Invokana lead September's $231M in pharma TV ad spending and more... |
| 2015-10-14 00:15 | | Big pharma fights California, Ohio voter initiatives and more... |
| 2015-10-13 12:15 | | These Big Pharma Companies Are in Need of an Acquisition and more... |
| 2015-10-13 00:15 | | FDA delays ruling on Collegium's opioid painkiller and more... |
| 2015-10-12 12:15 | | Lilly Loses Its Bloom; Amgen, Regeneron Blossom and more... |
| 2015-10-12 00:15 | | Advera Health Analytics: Novartis, Allergan Alzheimer's meds linked to abnormal behavior, blood pressure side effects and more... |
| 2015-10-10 12:15 | | Biogen And Four Other Biotech Stocks Worth Watching and more... |
| 2015-10-10 00:15 | | Biogen's Commercial Head Exits as Drugmaker Reshuffles Sales and more... |
| 2015-10-09 12:15 | | Wyeth, Cordis bury the hatchet in stent patent spat with Abbott, Boston Scientific and more... |
| 2015-10-09 00:15 | | Roche drug may set new benchmark in MS, data suggest and more... |
| 2015-10-08 12:15 | | Drugs Could Soon Come With a Money-Back Guarantee and more... |
| 2015-10-08 00:15 | | Analyst: New obstacles for Perrigo's businesses could thwart Mylan's deal logic and more... |
| 2015-10-07 12:15 | | Why Is The Placebo Effect Exploding In The U.S. But Nowhere Else? and more... |
| 2015-10-07 00:15 | | Sarepta Therapeutics vs. BioMarin Pharmaceutical: Which Company Will Win the DMD Race? and more... |
| 2015-10-06 12:15 | | Genentech, Exelixis score another PhIII success for cobimetinib and more... |
| 2015-10-06 00:15 | | How Martin Shkreli prevents generic versions of his pricey pill and more... |
| 2015-10-05 12:15 | | Beset by controversy, Turing unveils its first in-house drug candidate and more... |
| 2015-10-05 00:15 | | Yes, the Biotech Crash Could Actually Get Worse |
| 2015-10-04 12:15 | | Stem cell clinical trials are multiplying |
| 2015-10-04 00:15 | | Pfizer Raised Prices on 133 Drugs This Year, And It's Not Alone and more... |
| 2015-10-03 00:15 | | Merck's Keytruda snags FDA approval for NSCLC, but label is narrow and more... |
| 2015-10-02 12:15 | | Many UK doctors have a negative view of the pharmaceutical industry and more... |
| 2015-10-02 00:15 | | Drugmaker Tactic to Block Generics May Violate Law, FTC Says and more... |
| 2015-10-01 12:15 | | Perrigo Company Reported To be Urged by Shareholders To Explore Options Beyond Mylan NV and more... |
| 2015-10-01 00:15 | | Which Big Pharma Will Grab the Lion’s Share of the Cancer Immunotherapy Market? and more... |
